Kyndryl Inc. (KD)

KD trades at $29.46, 5.0% below the near-term max pain of $31 expiring Oct 17, 2025 (19 days). Price stability likely with balanced options positioning at this level. Max pain is rising across expirations ($20-$32), reflecting growing call interest at higher strikes. Key magnetic zone at 30 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for KD shows an upward trend from 20 to 32, suggesting bullish positioning in longer-dated options. The 42% spread signals divergent expectations across timeframes. Most levels above 29.46 could support dips. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.